NovaVive Inc. - Canine

NovaVive Inc. - Canine NovaVive offers a regulator-approved immunotherapy for canine mammary cancer in the USA and Canada. NovaVive Inc.

is an animal health immunobiology company with a regulator-approved canine cancer product available to veterinarians in CA and the US.

Immunocidin® immunotherapy has proven safe and effective as an intratumoral treatment for canine mammary cancer. Further...
06/24/2025

Immunocidin® immunotherapy has proven safe and effective as an intratumoral treatment for canine mammary cancer. Further research has demonstrated that it can also be safely administered by IV injection.

Immunocidin is approved by regulators in the USA and Canada. Research is ongoing with this product in various tumor types using different administration methods.

Visit NovaVive.ca/products for more information.

Immunocidin® immunotherapy is approved in the USA and Canada for the treatment of canine mammary cancer, but it is being...
06/18/2025

Immunocidin® immunotherapy is approved in the USA and Canada for the treatment of canine mammary cancer, but it is being used experimentally to treat a variety of other cancer types.

Immunocidin has also proven helpful as a palliative (end-of-life) support for dogs when treatment is no longer an option.

It is safe to use in all veterinary clinics.

Learn more at NovaVive.ca/products or ask your veterinarian to contact us.

Scarlet sadly lost her battle with cancer. However, we were glad to be able to offer support for more than four years af...
06/10/2025

Scarlet sadly lost her battle with cancer. However, we were glad to be able to offer support for more than four years after her cancer diagnosis.

Our Immunocidin immunotherapy is regulator-approved in the USA and Canada for the treatment of canine mammary cancer, but it is being used experimentally to treat a variety of other cancer types, including osteosarcoma.

Immunocidin has also proven helpful as a palliative (end-of-life) support for dogs when treatment is no longer an option.

Learn more at NovaVive.ca/products or ask your veterinarian to contact us.

Murphy sadly lost his battle with cancer. However, we were glad to be able to offer support in the last several weeks of...
06/03/2025

Murphy sadly lost his battle with cancer. However, we were glad to be able to offer support in the last several weeks of his life.

Our Immunocidin immunotherapy is regulator-approved in the USA and Canada for the treatment of canine mammary cancer, but it is being used experimentally to treat a variety of other cancer types.

Immunocidin has also proven helpful as a palliative (end-of-life) support for dogs when treatment is no longer an option.

Learn more at NovaVive.ca/products or ask your veterinarian to contact us.

Immunocidin immunotherapy is approved by regulators in the USA and Canada for the treatment of canine mammary cancer.Nov...
05/27/2025

Immunocidin immunotherapy is approved by regulators in the USA and Canada for the treatment of canine mammary cancer.

NovaVive continues to explore other cancers for which Immunocidin may be effective. One of these is osteosarcoma (bone cancer).

Learn more about Immunocidin research at http://novavive.ca/canine-research.

Immunocidin is approved by regulators in the USA and Canada for the treatment of canine mammary cancer and is undergoing...
05/21/2025

Immunocidin is approved by regulators in the USA and Canada for the treatment of canine mammary cancer and is undergoing further research in other tumor types including transitional cell carcinoma.

We’re pleased to help dogs like Kiska live their best lives despite a cancer diagnosis.

Visit NovaVive.ca/products to learn more.

Immunocidin is approved by regulators in the USA and Canada for the treatment of canine mammary cancer and is undergoing...
05/13/2025

Immunocidin is approved by regulators in the USA and Canada for the treatment of canine mammary cancer and is undergoing further research in other tumor types like transitional cell carcinoma.

We’re pleased to help dogs like Hana live their best lives despite a cancer diagnosis.

Visit NovaVive.ca/products to learn more.

Immunocidin® immunotherapy works by stimulating direct and indirect anticancer activity in the dog. The product is appro...
05/06/2025

Immunocidin® immunotherapy works by stimulating direct and indirect anticancer activity in the dog.

The product is approved in the USA and Canada for treating canine mammary cancer and research is ongoing in other tumor types.

Visit NovaVive.ca/products to learn more.

NovaVive’s production process adheres to strict sterility standards, and all products undergo in-house testing to ensure...
05/01/2025

NovaVive’s production process adheres to strict sterility standards, and all products undergo in-house testing to ensure purity, safety and potency.

Each batch is then reviewed by the USDA prior to its release into the market.

Visit NovaVive.ca for more information.

Here's an update on Katya (the Amur tiger)'s treatment with our Immunocidin immunotherapy. We're so pleased to hear that...
04/24/2025

Here's an update on Katya (the Amur tiger)'s treatment with our Immunocidin immunotherapy. We're so pleased to hear that her bladder tumor is shrinking! Another win for Immunocidin!

The veterinary team at Seneca Park Zoo has confirmed that Katya, our nearly 20-year-old female Amur tiger, is undergoing treatment for a noncancerous tumor on her bladder wall.

“We discovered the mass during a routine physical evaluation about a year ago,” said Seneca Park Zoo Veterinarian Dr. Chris McKinney. “Given her advanced age, and because testing indicates it is likely a noncancerous tumor, surgery is not an option. We began a protocol of Immunocidin, the same medication we used to slow the growth of Masai giraffe Kipenzi’s malignant tumor.”

On March 20, 2025, Katya was sedated for treatment of an ingrown nail, common in geriatric big cats, and for an ultrasound of her bladder to check the tumor. The ultrasound shows that the bladder tumor has reduced in size about one-third since February 2024.

“Clearly, the medication is helping, and Katya has not shown any symptoms related to her tumor,” Dr. McKinney continues. “Her blood work also looks very good. She does have some arthritis which is very common at her age. She receives weekly laser therapy for her hips and shoulders, as well as medications to reduce inflammation to help alleviate arthritic symptoms.”

“Katya’s advanced age is a testament to the care she receives from our Animal Health and Animal Care teams,” said Seneca Park Zoo Director Bob Lee. “Our teams will continue to monitor Katya closely for any changes in health.”

To read the complete press release, visit:https://senecaparkzoo.org/wp-content/uploads/2025/04/Seneca-Park-Zoo-Amur-Tiger-Treated-for-Nonmalignant-Tumor.pdf

Address

15 Dairy Avenue
Napanee, ON
K7R1M4

Alerts

Be the first to know and let us send you an email when NovaVive Inc. - Canine posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to NovaVive Inc. - Canine:

Share